Stanley Cohen Archives
Hodges, Nakagawa receive Cohen Innovation funds
Sep. 14, 2022—Emily Hodges, PhD, assistant professor of Biochemistry, and Terunaga Nakagawa, MD, PhD, associate professor of Molecular Physiology and Biophysics, were named as the 2022 recipients of Stanley Cohen Innovation Funds
Nobel Prize-winning biochemist Stanley Cohen dies at 97
Feb. 6, 2020—Vanderbilt University biochemist Stanley Cohen, PhD, whose discovery of epidermal growth factor (EGF) and its receptor earned him a Nobel Prize and opened the door to a new class of cancer therapies, died Wednesday, Feb. 5, in Nashville. He was 97.
Exhibit translates scientific discoveries into art celebrating Vanderbilt’s Nobel laureates
Oct. 13, 2017—A new exhibit on display at the Wond'ry honors the discoveries of Vanderbilt's Nobel laureates by translating them into beautiful works of art.
Call for applications: 2017 Stanley Cohen Innovation Fund
Feb. 28, 2017—The Vanderbilt University School of Medicine is now soliciting applications for research awards from the Stanley Cohen Innovation Fund.
New fund honors spirit of Cohen’s innovative research
Aug. 25, 2016—When Tom Daniel, M.D., joined the Vanderbilt University faculty in December 1986, Stanley Cohen, Ph.D., had just been awarded the Nobel Prize in Physiology or Medicine for his discovery of epidermal growth factor (EGF).
VU study identifies new mechanism for cancer development
Jun. 6, 2013—Researchers at Vanderbilt University Medical Center led by a 32-year-old postdoctoral fellow have discovered a new mechanism for the development of cancer that is challenging conventional scientific wisdom.
Nobel in Chemistry reveals VU ties that bind
Oct. 18, 2012—Several Vanderbilt researchers have collaborated with this year's Nobel Chemistry winners.
